Power Wheelchair Group 2 denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's Commercial policy states that mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POVs), canes, and walkers are a covered health care service when medically necessary. The policy applies the Medicare DME MAC LCD for Power Mobility Devices (L33789) criteria, which require that the beneficiary has a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home, where the mobility limitation prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completion within a reasonable time frame. The beneficiary's mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. For a Group 2 Single Power Option PWC (K0835–K0840), all basic coverage criteria (a)–(e) must be met, plus the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick (e.g., head control, sip and puff, switch control), OR meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair, AND has had a specialty evaluation performed by a licensed/certified medical professional (PT, OT, or practitioner) with specific training and experience in rehabilitation wheelchair evaluations documenting medical necessity. The wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. Section 6407 of the ACA requires a face-to-face encounter, documented by a physician (or NP, PA, or CNS), occurring within the 6 months before the order is written for the DME. Weight-class criteria apply: a Heavy Duty PWC is covered for beneficiaries weighing 285–450 pounds, Very Heavy Duty for 428–600 pounds, and Extra Heavy Duty for 570 pounds or more. Payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document in-home MRADL impairment in detail** — Provide specific examples of how the member cannot independently/safely complete toileting, feeding, dressing, grooming, or bathing in the home, mapping directly to the LCD MRADL definition: a mobility limitation that prevents accomplishment of an MRADL, places the beneficiary at heightened risk of morbidity/mortality, or prevents completion within a reasonable time frame. - **Demonstrate failure of lesser alternatives** — Include PT/OT trial documentation showing that the beneficiary lacks sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day due to weakness, fatigue, pain, ROM limits, or absent extremities, satisfying LCD basic criterion C. - **Submit a compliant specialty evaluation and ATP attestation** — Provide the LCMP/PT/OT evaluation with the no-financial-relationship attestation per the requirement of a signed and dated attestation by the supplier or LCMP that the LCMP has no financial relationship with the supplier , plus documentation that the wheelchair is provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. - **Justify the Group 2 power option upgrade** — For K0835–K0840, document either a non-standard drive control need (head control, sip-and-puff, switch) OR concurrent need for a power tilt/recline system per the LCD requirement that the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick, or meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair. - **Provide a timely 7-element order and face-to-face note** — Submit the in-window F2F note and order; per the LCD policy article, the 7-element order must be received by the supplier within 45 days after completion of the face-to-face examination , and per CMS, the encounter must occur within the 6 months before the order is written. - **Verify accurate weight-class coding** — Confirm the member's weight aligns with the prescribed class boundaries set by the LCD: Heavy Duty 285–450 lb, Very Heavy Duty 428–600 lb, and Extra Heavy Duty 570 lb or more , and amend the HCPCS code if a misclassification triggered the denial. - **Cite clinical/professional standards** — Reference RESNA's position papers on the application of power wheelchairs and seat-elevation/tilt systems, and AOTA/APTA wheelchair assessment guidelines, to support the medical necessity narrative that mirrors LCD L33789 — the framework UnitedHealthcare explicitly adopts via its Mobility Devices policy and the DME MAC LCD for Power Mobility Devices (L33789).

## Why UnitedHealthcare Denied Your Group 2 Power Wheelchair as "Duplicate Therapy"

A duplicate-therapy denial for a Group 2 power wheelchair means UHC's system found an existing active claim or authorization for the same or a similar device for the same member. This most commonly occurs when a prior wheelchair authorization is still open in UHC's records, when a replacement is requested while the prior unit's coverage period has not technically expired, or when a billing code submitted is identical to one previously paid. It is often a data or administrative problem rather than a clinical one.

## Why This Denial Is Appealable

Duplicate-therapy flags are frequently erroneous. If the prior device is no longer functional, was never delivered, or was authorized for a different purpose or time period, the duplication label does not apply. Administrative denials like this are regularly reversed on appeal once accurate records are provided.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 (employer plans) or applicable state law within the deadline stated on your EOB.
• External review: Available under ACA §2719 after a final internal adverse decision. An independent reviewer can assess whether the duplicate classification was accurate.
• Expedited review: Request if your mobility needs create an urgent situation.
• Window: External review must generally be requested within four months of a final adverse determination.

## Concrete Appeal Steps

1. Call UHC's DME department to identify the specific prior claim or authorization their system flagged as duplicative. 2. Obtain records for the prior device: authorization date, delivery confirmation, and current status. 3. Document why the current request is not a duplicate: the prior device is no longer serviceable, authorization has expired, or the clinical need has changed. 4. Submit a written internal appeal with a clear timeline distinguishing the prior equipment from the current request. 5. Escalate to external review if the internal appeal is unsuccessful.

## Documentation to Gather

• Prior authorization records and their effective and expiration dates
• Supplier confirmation of whether the prior device was delivered and its current status
• Repair or damage assessment if the prior unit is the basis for replacement
• Prescriber statement clarifying that the current request is not duplicative of previously authorized equipment
• Clinical records documenting any change in condition if relevant

## Criteria-Mapping Structure

Obtain UHC's published DME coverage policy. Identify which duplication rule was applied. Address each element directly: show that the prior claim is distinct from the current request by date, device status, or clinical indication. A clear, factual rebuttal of the specific duplication rationale — supported by supplier and clinical records — is the most effective appeal structure.